The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 26, 2025

Filed:

Nov. 11, 2022
Applicant:

Shanghai Ruizhikang Medical Technology Co., Ltd., Shanghai, CN;

Inventors:

Xiaohong Chen, Shanghai, CN;

Yubo Liu, Shanghai, CN;

Honglei Zhou, Shanghai, CN;

Wei Li, Shanghai, CN;

Fengcang Ma, Shanghai, CN;

Shaoli Fu, Shanghai, CN;

Guosen Shao, Shanghai, CN;

Haochen Wu, Shanghai, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 15/26 (2006.01); A61L 15/20 (2006.01); A61L 15/28 (2006.01); A61L 15/32 (2006.01); A61L 15/44 (2006.01); D01F 1/10 (2006.01); D01F 8/02 (2006.01);
U.S. Cl.
CPC ...
A61L 15/26 (2013.01); A61L 15/20 (2013.01); A61L 15/28 (2013.01); A61L 15/32 (2013.01); A61L 15/44 (2013.01); D01F 1/10 (2013.01); D01F 8/02 (2013.01);
Abstract

The present disclosure provides a hydrophilic fiber membrane with a sustained-release drug, and belongs to the field of biological materials. The present disclosure provides a hydrophilic fiber membrane with a sustained-release drug, including a fiber with a core-shell structure, where a core of the fiber includes curcumin and a first spinnable polymer, and a shell of the fiber includes polyethylene glycol and a second spinnable polymer; and in the shell, the polyethylene glycol and the second spinnable polymer have a mass ratio of not greater than 1:12. In the present disclosure, the fiber membrane has a core-shell structure, the curcumin is provided in the core, and the shell prevents a rapid release of the curcumin in an early stage, thereby delaying a release rate of the curcumin to prevent the drug from forming a burst release in the early stage and causing toxic reactions.


Find Patent Forward Citations

Loading…